Diagnostic tools: Various tests to diagnose and manage hepatitis C including various biochemical marker, imaging, liver biopsy for grading/staging liver disease and HCV RNA (viral load) tests.

 

 

        Biochemical/Imaging

o       437. Point Of Care Non-Invasive 13C Methacetin Breath Testing Accurately Identifies Significant Liver Inflammation and Fibrosis: A Novel Method For Assessing Liver Damage

o       S1000. Identification of Novel Biomarker Profiles in Hepatitis C Positive Liver Cancer Patients. (updated, May 20)

o       S1226. Diagnostic value of biochemical markers for prediction of liver fibrosis and inflammation in pediatric patients

 

        General

o       585. Elevated levels of circulating mesenchymal stem cells in patients with chronic hepatitis B and C.

 

        Non-invasive markers

o       M1833. Investigating the Cause of High Ast/Alt Ratio in HCV-Induced Liver Cirrhosis.

o       M1842. Transient elastography in chronic hepatitis B and C predicts severe fibrosis similarly.

o       M1844. Point of Care Non-Invasive 13C Methacetin Breath Testing Accurately Identifies Significant Liver Inflammation and Fibrosis: A Novel Method For Assessing Liver Damage. (updated, May 21)

o       S1004. A Comparison of Alphafetoprotein, AFP-L3% and Des-Gamma Carboxyprothrombin in Patients with Chronic Hepatitis, Cirrhosis and Hepatocellular Carcinoma. (updated, May 20)